Did someone say double digits? Rumor has it the MGB PIKASO team had their 10th baseline visit last week. 🤫 Way to go team!🥳 Read more about the study here:
Happy Monday! What better way to start your week than getting to know OrACORe director Dr. Katz? ☀️Follow the link to check out our most recent blog post on the fascinating life and career of Jeff. https://t.co/tCz99O9nsl
A little birdie told me the CoMeT study surpassed 90 randomizations last week... You guys are unstoppable! 💫🌟🌠
For more information on the CoMeT study, click here: https://t.co/2d5mqqdYli
With our colleagues at University of Kentucky now officially recruiting, we now have 6/9 PIKASO sites actively up and running! Three more to go and this study will be enrolling with full force 💪💪
https://t.co/TYngXYVagR
Osteoarthritis is a complicated disease to study, but @JasonKimAF, PhD, VP of Osteoarthritis Research, is focused on bringing together patients, scientists and health care providers to improve infrastructure of clinical trials. https://t.co/48QDYJT178
#ArthritisScience
The amazing Lily Waddell of @OrACORe_BWH profiled for her work in #osteoarthritis and the @ArthritisFdn sponsored PIKASO Trial studying metformin in knees at risk of PTOA.
Read her Q&A here! https://t.co/EiTmctMFLK
We worked with @HSSProfEd to think and talk about hip #osteoarthritis--and now are issuing an RFP
with the goal of identifying patients with risk of accelerated hip OA for future clinical studies.
See RFP and Apply Here:
https://t.co/YiamJYbVGi
Hip, hip, hooray - our November special issue on the 2023 Hip Osteoarthritis Clinical Studies Conference, a collaboration of @ArthritisFdn and @HSpecialSurgery, is online! #OrthoTwitter https://t.co/TvnhVftfWo
Hip, hip, hooray - our November special issue on the 2023 Hip Osteoarthritis Clinical Studies Conference, a collaboration of @ArthritisFdn and @HSpecialSurgery, is online! #OrthoTwitter https://t.co/TvnhVftfWo
Deadline to submit letters of intent for our 2023 Rheumatoid Arthritis Research Program is this Wed., May 17. Grant funding is available for projects designed to improve understanding of how patients with RA respond to varying therapeutics. https://t.co/RWdtU0kqGM
The first OA Innovation Shark Tank program tomorrow, hosted by @AngryArthritis and the @ArthritisFdn, will bring together the leading minds in OA research to present their treatments, opinions, research, and human clinical trial data.
More info here: https://t.co/MmhzxVnzFJ
Thank you to the @ArthritisFdn, our speakers, and everyone who attended to support our mission today. Stay connected with us on our website as we work to achieve the promise of new treatments to cure osteoarthritis: https://t.co/ncrxyERE7l (3/3)